Gatifloxacin: An 8-methoxy fluoroquinolone characterized by dual-target inhibition of bacterial DNA gyrase and Topoisomerase IV. It demonstrates excellent corneal penetration and broad-spectrum coverage, effectively eradicating common conjunctival and corneal isolates.
Indications
Treatment of bacterial conjunctivitis caused by susceptible organisms
Superficial ocular bacterial infections as advised by the treating ophthalmologist
Note: This is an indicative Indication, please follow the doctors advise. Do not self medicate.
Dosage & Administration
Instill 1 drop into the inferior conjunctival cul-de-sac of the affected eye(s) as prescribed by the physician. Dosing frequency should be adjusted according to clinical response and severity.
Note: This is an indicative dosage, please follow the doctors advise. Do not self medicate.
References
1. Perry HD, et al. Gatifloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Ophthalmology. 2005;112(1):86-90.
2. Mather R, et al. The susceptibility of ocular pathogens to gatifloxacin and other fluoroquinolones. Am J Ophthalmol. 2002;133(4):463-466.
Warning: This information is only for the use of registered medical practitioners only.
Certified Manufacturing Standards
Disclaimer: This content is compiled from various references. We do not endorse any of it. Readers are advised not to self-medicate and to follow a doctor’s prescription and guidance.